Ryan Spencer
Co-President and Senior VP, DYNAVAX TECHNOLOGIES CORP.
Companies
- Cidara TherapeuticsBoard member Apr 30, 2024 to now1
- DYNAVAX TECHNOLOGIES CORPBoard member Dec 17, 2019 to now2
- DYNAVAX TECHNOLOGIES CORPChief executive officer Dec 17, 2019 to now2
- DYNAVAX TECHNOLOGIES CORPCo-President and Senior VP May 31, 2019 to Jun 18, 20193
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- DYNAVAX TECHNOLOGIES CORP0 shares4Feb 10, 2026
As of each latest filing. The line shows shares held over time.
Recent filings
- Feb 10, 2026Returned to company 136,000 shares of DYNAVAX TECHNOLOGIES CORP4
- Feb 10, 2026Granted 136,000 shares of DYNAVAX TECHNOLOGIES CORP4
- Feb 10, 2026Returned to company 165,000 shares of DYNAVAX TECHNOLOGIES CORP4
- Feb 10, 2026Granted 165,000 shares of DYNAVAX TECHNOLOGIES CORP4
- Feb 10, 2026U 379,620 shares of DYNAVAX TECHNOLOGIES CORP4
- Dec 24, 2025Shares withheld for tax 138,168 shares at $15.38 of DYNAVAX TECHNOLOGIES CORP5
- Dec 23, 2025Exercised options 45,333 shares of DYNAVAX TECHNOLOGIES CORP5
- Dec 23, 2025Exercised options 55,000 shares of DYNAVAX TECHNOLOGIES CORP5
- Dec 23, 2025Granted 156,250 shares of DYNAVAX TECHNOLOGIES CORP5
- Feb 18, 2025Shares withheld for tax 36,528 shares at $12.93 of DYNAVAX TECHNOLOGIES CORP6
- Feb 18, 2025Exercised options 55,000 shares of DYNAVAX TECHNOLOGIES CORP6
- Feb 13, 2025Shares withheld for tax 31,694 shares at $12.69 of DYNAVAX TECHNOLOGIES CORP7
- Feb 13, 2025Exercised options 62,500 shares of DYNAVAX TECHNOLOGIES CORP7
- Feb 10, 2025Shares withheld for tax 11,209 shares at $13.20 of DYNAVAX TECHNOLOGIES CORP8
- Feb 10, 2025Exercised options 20,833 shares of DYNAVAX TECHNOLOGIES CORP8
- Feb 15, 2024Granted 402 shares at $9.45 of DYNAVAX TECHNOLOGIES CORP9
- Feb 12, 2024Shares withheld for tax 11,684 shares at $12.82 of DYNAVAX TECHNOLOGIES CORP10
- Feb 10, 2024Exercised options 20,833 shares of DYNAVAX TECHNOLOGIES CORP10
- Feb 5, 2024Shares withheld for tax 17,129 shares at $12.79 of DYNAVAX TECHNOLOGIES CORP11
- Feb 4, 2024Exercised options 29,750 shares of DYNAVAX TECHNOLOGIES CORP11
- Feb 27, 2023Shares withheld for tax 14,673 shares at $10.36 of DYNAVAX TECHNOLOGIES CORP12
- Feb 27, 2023Exercised options 29,750 shares of DYNAVAX TECHNOLOGIES CORP12
- Feb 27, 2023Shares withheld for tax 10,637 shares at $10.36 of DYNAVAX TECHNOLOGIES CORP12
- Feb 27, 2023Exercised options 20,834 shares of DYNAVAX TECHNOLOGIES CORP12
- Feb 27, 2023Shares withheld for tax 4,670 shares at $10.36 of DYNAVAX TECHNOLOGIES CORP12
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1SEC EDGARCidara Therapeutics, Board member
- 2
- 3
- 4
- 5SEC EDGARForm 4 filed Dec 29, 2025
- 6SEC EDGARForm 4 filed Feb 20, 2025
- 7SEC EDGARForm 4 filed Feb 18, 2025
- 8SEC EDGARForm 4 filed Feb 12, 2025
- 9SEC EDGARForm 4 filed Feb 20, 2024
- 10SEC EDGARForm 4 filed Feb 13, 2024
- 11SEC EDGARForm 4 filed Feb 6, 2024
- 12SEC EDGARForm 4 filed Mar 1, 2023